Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab

Marco H. Ji, Darius M. Moshfeghi, Natalia F. Callaway, Zachary Bodnar, Ira H. Schachar, Giulia Maria Amorelli, Lorenzo Orazi, Fernando Molle, Domenico Lepore

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

N/A
Original languageEnglish
Pages (from-to)913-915
Number of pages3
JournalOphthalmology Retina
Volume3
DOIs
Publication statusPublished - 2019

Keywords

  • Angiogenesis Inhibitors
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Infant, Newborn
  • Intravitreal Injections
  • Male
  • Ranibizumab
  • Recurrence
  • Retina
  • Retinopathy of Prematurity
  • Time Factors
  • Vascular Endothelial Growth Factor A

Fingerprint

Dive into the research topics of 'Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab'. Together they form a unique fingerprint.

Cite this